The increased risk of stroke associated with atrial fibrillation (AF) is often managed through the long-term use of oral anticoagulation. A significant proportion of patients with AF also present with concomitant acute coronary syndrome (ACS) and/or require percutaneous coronary intervention (PCI), necessitating use of antiplatelet therapy to prevent coronary thrombosis. This represents a major clinical conundrum, which will be examined extensively in the following e-learning modules.
Learn more about the clinical dilemma that arises when treating patients with atrial fibrillation who present with ACS and/or require PCI.
Using a unique study design, the AUGUSTUS trial addressed two of the most important unanswered questions regarding the treatment of patients with atrial fibrillation who present with ACS and/or require PCI.
Alternatively login via
Back to epgonline.org